BSE Live
Dec 31, 16:01Prev. Close
72.60
Open Price
72.00
Bid Price (Qty.)
71.20 (2)
Offer Price (Qty.)
77.50 (125)
NSE Live
Dec 31, 15:40Prev. Close
72.44
Open Price
72.44
Bid Price (Qty.)
73.32 (20)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Bal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 293.69 | 325.67 | 300.59 | 278.85 | 245.74 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 293.69 | 325.67 | 300.59 | 278.85 | 245.74 | |
| Total Operating Revenues | 302.50 | 338.54 | 303.10 | 280.37 | 249.31 | |
| Other Income | 2.15 | 3.35 | 2.15 | 6.49 | 2.69 | |
| Total Revenue | 304.65 | 341.89 | 305.25 | 286.86 | 252.00 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 149.89 | 181.57 | 176.45 | 162.95 | 135.47 | |
| Purchase Of Stock-In Trade | 14.97 | 11.23 | 11.39 | 8.40 | 9.98 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -7.08 | -1.06 | -17.90 | -4.85 | 5.13 | |
| Employee Benefit Expenses | 61.83 | 56.11 | 51.91 | 44.46 | 39.62 | |
| Finance Costs | 16.85 | 15.24 | 12.16 | 10.40 | 11.96 | |
| Depreciation And Amortisation Expenses | 9.65 | 8.45 | 7.48 | 7.24 | 7.26 | |
| Other Expenses | 52.82 | 58.25 | 55.22 | 46.21 | 32.79 | |
| Total Expenses | 298.91 | 329.79 | 296.70 | 274.80 | 242.20 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5.73 | 12.11 | 8.55 | 12.06 | 9.80 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 5.73 | 12.11 | 8.55 | 12.06 | 9.80 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 3.20 | 2.58 | 4.48 | 0.38 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -1.93 | 1.08 | 0.39 | -1.94 | 0.32 | |
| Tax For Earlier Years | -0.14 | -2.45 | -0.55 | 0.94 | 0.00 | |
| Total Tax Expenses | -2.07 | 1.83 | 2.42 | 3.48 | 0.70 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 7.80 | 10.27 | 6.13 | 8.58 | 9.10 | |
| Profit/Loss From Continuing Operations | 7.80 | 10.27 | 6.13 | 8.58 | 9.10 | |
| Profit/Loss For The Period | 7.80 | 10.27 | 6.13 | 8.58 | 9.10 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 4.89 | 6.72 | 3.90 | 5.79 | 6.41 | |
| Diluted EPS (Rs.) | 4.89 | 6.75 | 3.94 | 5.79 | 6.41 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 58.88 | 69.27 | 0.00 | 0.00 | 55.17 | |
| Indigenous Raw Materials | 91.01 | 112.30 | 0.00 | 0.00 | 70.22 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 1.91 | 1.57 | 1.56 | 1.48 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 12.00 | 12.00 | 10.00 | 10.00 | 10.00 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y